Skip to content
Nonprofiteer
← DAVOS ALZHEIMERS COLLABORATIVE INC

Form 990 for tax year 2025

Filed by DAVOS ALZHEIMERS COLLABORATIVE INC.

Totals

Total revenue
$12,470,622
Total expenses
$16,083,398
Contributions and grants received
$12,186,383
Grants paid
$3,542,155
Program service revenue
$60,000
Investment income
$224,239
Other revenue
$0
Total assets, end of year
$8,470,178
Total liabilities, end of year
$577,289
Net assets or fund balances, end of year
$7,892,889
Program services expenses (Part IX)
$14,834,609
Management and general expenses
$496,089
Fundraising expenses
$752,700
Program service expenses (Part III)
$14,834,609

Program services were 92.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $12,186,383

  • 1g · Noncash contributions included above

    $4,905,928

  • 2a · Program service revenue: CONTRACT INCOME

    total $60,000 · related or exempt $60,000

  • 3 · Investment income

    total $224,239 · excluded $224,239

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $2,323,750 · program services $2,323,750

  • 3 · Grants to foreign organizations and individuals

    total $1,218,405 · program services $1,218,405

  • 11a · Fees: management

    total $997,537 · program services $927,417 · management and general $38,528 · fundraising $31,592

  • 11b · Fees: legal

    total $183,815 · program services $170,894 · management and general $7,100 · fundraising $5,821

  • 11c · Fees: accounting

    total $207,171 · management and general $207,171

  • 11g · Fees: other

    total $9,577,907 · program services $9,099,836 · management and general $168,089 · fundraising $309,982

  • 12 · Advertising and promotion

    total $195,886 · program services $159,518 · management and general $200 · fundraising $36,168

  • 13 · Office expenses

    total $19,081 · program services $3,797 · management and general $15,085 · fundraising $199

  • 14 · Information technology

    total $11,082 · program services $2,205 · management and general $8,763 · fundraising $114

  • 17 · Travel

    total $1,298,502 · program services $918,767 · management and general $11,430 · fundraising $368,305

  • 23 · Insurance

    total $21,251 · program services $4,228 · management and general $16,804 · fundraising $219

  • 24a · Other expenses: BAD DEBT

    total $25,000 · program services $4,974 · management and general $19,768 · fundraising $258

  • 24b · Other expenses: SUBSCRIPTION FEES

    total $2,238 · program services $445 · management and general $1,770 · fundraising $23

  • 24c · Other expenses: MISCELLANEOUS

    total $1,773 · program services $373 · management and general $1,381 · fundraising $19

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $9,007,029 · end of year $952,856

  • 2 · Savings and temporary cash investments

    end of year $5,988,759

  • 3 · Pledges and grants receivable

    beginning of year $3,895,504 · end of year $1,427,470

  • 9 · Prepaid expenses and deferred charges

    beginning of year $469,884 · end of year $101,093

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,870,549 · end of year $577,289

  • 27 · Net assets without donor restrictions

    beginning of year $7,659,407 · end of year $3,998,205

  • 28 · Net assets with donor restrictions

    beginning of year $3,842,461 · end of year $3,894,684

Mission and programs · 2025

Mission

DAC IS LEADING THE LARGEST GLOBAL RESPONSE OF ITS KIND, DRIVING SCIENTIFIC DISCOVERY AND ALIGNING HEALTH SYSTEMS TO HELP PEOPLE WORLDWIDE, INCLUDING THOSE IN LOW RESOURCED ENVIRONMENTS LEFT OUT OF PREVIOUS EFFORTS TO FIGHT ALZHEIMER'S. (SEE SCHEDULE O)WE ARE COMMITTED TO TRANSFORMING ALZHEIMER'S RESEARCH, PREVENTION AND CARE THROUGH PROVEN PRIVATE-PUBLIC MODELS, SUCH AS GAVI, CEPI AND THE GLOBAL FUND.

Activities or mission (Part I)

SEE PART III LINE 1.

  • THE DAVOS ALZHEIMER'S COLLABORATIVE'S SYSTEM PREPAREDNESS PROGRAM AIMS TO STRENGTHEN HEALTHCARE SYSTEMS' ABILITY TO IDENTIFY AND ADDRESS ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) EARLY. KEY INITIATIVES INCLUDE THE EARLY DETECTION FELLOWSHIP, WHICH OFFERS TECHNICAL ASSISTANCE AND FUNDING TO HEALTHCARE ORGANIZATIONS (HCOS) TO IMPLEMENT THE EARLY DETECTION BLUEPRINT, FOSTERING COLLABORATION AMONG SELECTED SITES TO OVERCOME BARRIERS AND ENHANCE EARLY DETECTION. THE PROGRAM ALSO INCLUDES THE BRAIN HEALTH NAVIGATOR INITIATIVE, DESIGNED TO PILOT A BRAIN HEALTH NAVIGATOR MODEL IN SIX HCOS TO SUPPORT TIMELY CARE FOR PATIENTS WITH COGNITIVE DECLINE. ADDITIONALLY, THE ACCURATE DIAGNOSIS PROGRAM AIMS TO INCREASE THE USE OF NEW DIAGNOSTIC TOOLS, HELPING HEALTHCARE SYSTEMS ADOPT MORE EFFECTIVE METHODS FOR DIAGNOSING AD/ADRD. THESE EFFORTS ARE SUPPORTED BY SIGNIFICANT FUNDING AND ARE INTENDED TO IMPROVE SYSTEM PREPAREDNESS THROUGH OUTREACH, TRAINING, AND THE CREATION OF PRACTICAL TOOLKITS FOR HEALTHCARE PROVIDERS.OVERALL, OUTPUTS INCLUDE PEER-REVIEWED PUBLICATIONS, SYMPOSIUMS, POLICY COMMUNICATIONS, AND AN OPEN-ACCESS "BLUEPRINT" FOR AD/ADRD EARLY DETECTION AND SYSTEM PREPAREDNESS. DAC ALSO COLLABORATES WITH OTHER ORGANIZATIONS TO ADDRESS COMMON BARRIERS AND PROMOTE BEST PRACTICES ACROSS HEALTH SYSTEMS.

    Expenses $13,167,569 · Grants $3,538,155

  • THE DAVOS ALZHEIMER'S COLLABORATIVE'S GLOBAL COHORT DEVELOPMENT PROGRAM FOCUSES ON BUILDING A DIVERSE AND SUSTAINABLE NETWORK OF COHORTS TO ADVANCE ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) RESEARCH. THIS INCLUDES PARTNERSHIPS SUCH AS THE COLLABORATION WITH AGA KHAN UNIVERSITY IN NAIROBI, KENYA, WHERE COGNITIVE TESTS, SALIVA-BASED POLYGENIC RISK SCORES, AND DIGITAL COGNITIVE ASSESSMENTS ARE BEING VALIDATED IN EAST AFRICAN POPULATIONS TO CREATE A CLINICAL TRIAL-READY COHORT. IN SOUTH KOREA, DAC HAS ACQUIRED BLOOD SAMPLES FROM 300 PARTICIPANTS IN A HIGHLY CHARACTERIZED COHORT, ADVANCING THE VALIDATION OF BLOOD-BASED BIOMARKERS (BBMS) FOR GLOBAL USE. THE PROJECT ALSO INCLUDES ACCESS TO 1,000 BLOOD SAMPLES FROM A LONG-STANDING COHORT IN THE LATAM/CARIBBEAN REGION FOR AD BLOOD BIOMARKER VALIDATION, AS WELL AS A LARGE-SCALE CLINICAL TRIAL RECRUITMENT EFFORT IN THE DOMINICAN REPUBLIC, WITH OVER 14,000 PARTICIPANTS ACROSS URBAN AND RURAL SETTINGS.FURTHER EXPANDING GLOBAL RESEARCH, DAC IS DEVELOPING SCALABLE APPROACHES IN EGYPT FOR EARLY DETECTION, MONITORING, AND RISK REDUCTION OF AD, WHILE IN INDIA, THE "EYE-DEA STUDY" IS USING CATARACT SURGERY CLINICS TO ASSESS OCULAR, SPEECH, AND OLFACTORY BIOMARKERS RELATED TO COGNITIVE IMPAIRMENT. IN CHILE, DAC IS COLLECTING A WIDE RANGE OF DATA FROM A 9,000-PERSON COHORT TO GENERATE LOCAL VALIDATION DATA FOR BLOOD BIOMARKERS AND DIGITAL COGNITIVE ASSESSMENTS, PARTICULARLY FOCUSING ON THE IMPACT OF PESTICIDE USE AND EXPOSURE TO NEUROTOXINS. THESE EFFORTS ARE HELPING TO ENSURE THAT AD RESEARCH IS INCLUSIVE OF DIVERSE POPULATIONS AND ADAPTABLE TO LOCAL SETTINGS, WITH THE AIM OF IMPROVING EARLY DETECTION, DIAGNOSIS, AND TREATMENT ON A GLOBAL SCALE.

    Expenses $1,667,040 · Grants $4,000 · Revenue $60,000

  • THE DAVOS ALZHEIMER'S COLLABORATIVE'S GLOBAL CLINICAL TRIAL PROGRAM IS MAINTAINING A NETWORK OF MORE THAN 30 EUROPEAN SITES ORGANIZED TO ACCELERATE STUDIES AND IMPLEMENT NOVEL TRIAL DESIGNS. THIS EFFORT IS PART OF DAC'S BROADER GOAL TO BUILD INFRASTRUCTURE FOR FUTURE PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TRIALS GLOBALLY. THROUGH THE GLOBAL COHORT DEVELOPMENT PROGRAM, DAC IS WORKING TO CREATE CLINICAL TRIAL-READY POPULATIONS BY 2026, ENSURING THAT DIVERSE AND WELL-CHARACTERIZED COHORTS ARE PREPARED FOR BOTH TYPES OF INTERVENTIONS. THIS WILL EXPAND OPPORTUNITIES FOR GLOBAL CLINICAL TRIALS, ENHANCING THE ABILITY TO TEST NEW TREATMENTS AND APPROACHES IN ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) ACROSS VARIED POPULATIONS AND SETTINGS.

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • George Vradenburg

    CHAIR & PRESIDENT

    Total calculated
    $0
    Hours/week
    20 + 2 related
  • Andrew Holzapfel

    COO (SEE SCHEDULE O)

    Total calculated
    $0
    Hours/week
    30 + 3 related
  • Freda Lewis Hall

    TREASURER

    Total calculated
    $0
    Hours/week
    1 + 1 related

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
43
Expenditures and investments (line 3c)
$4,564,426

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION — $230,855
EUROPE 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION — $985,550
SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION — $2,000
EAST ASIA AND THE PACIFIC 0 1 PROGRAM SERVICES SCIENTIFIC RESEARCH FOR ALZHEIMER'S DISEASE $25,000
EUROPE 0 19 PROGRAM SERVICES PROFESSIONAL FEES, RESEARCH SERVICES, MARKETING, TRAVEL LEGAL SERVICES $1,696,041
MIDDLE EAST AND NORTH AFRICA 0 2 PROGRAM SERVICES RESEARCH SITE AND RESEARCH SERVICES $168,115
NORTH AMERICA 0 5 PROGRAM SERVICES PROGRAM SERVICES AND RESEARCH SITE $640,503
SOUTH AMERICA 0 4 PROGRAM SERVICES, RESEARCH SERVICES, RESEARCH SITE AND TRAVEL RESEARCH SITE, SPONSORSHIP AND PROGRAM SERVICES $572,520
SOUTH ASIA 0 2 RESEARCH SERVICES RESEARCH SITE, RESEARCH SERVICES AND TRAVEL $197,782
SUB-SAHARAN AFRICA 0 10 PROGRAM SERVICES RESEARCH SERVICES, MARKETING AND TRAVEL $46,060

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
EAST ASIA & THE PACIFIC $230,855 — $0 — —
EUROPE $325,000 — $0 — —
EUROPE $649,550 — $0 — —
EUROPE $11,000 — $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
4
Other grantees (Part II line 3)
0
Transferred property to a foreign corporation during the year (line 1)
Yes
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • DAVOS ALZHEIMER'S COLLABORATIVE (GENEVE)

    N/A · PROMOTE HEALTH BY DEVELOPING RESEARCH ON BRAIN HEALTH.. · SZ · controlled entity

    Directly controlled by DAC

Provenance

Return type
form_990
Tax year
2025
Filed
29 May 2026
IRS schema version
2025v4.1
Source object
202631499349301118

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.